NCT00040794View on ClinicalTrials.gov

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

March 31, 2006

Conditions

Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung CancerLarge Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer

Interventions

DRUG

paclitaxel

Given IV

DRUG

carboplatin

Given IV

DRUG

gefitinib

Given PO

RADIATION

radiation therapy

Undergo radiotherapy

OTHER

laboratory biomarker analysis

Optional correlative studies

Trial Locations (1)

60606

Cancer and Leukemia Group B, Chicago

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00040794 - Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter